K. Hewett

552 total citations
11 papers, 324 citations indexed

About

K. Hewett is a scholar working on Experimental and Cognitive Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, K. Hewett has authored 11 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Experimental and Cognitive Psychology, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in K. Hewett's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Treatment of Major Depression (4 papers) and Electroconvulsive Therapy Studies (3 papers). K. Hewett is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Treatment of Major Depression (4 papers) and Electroconvulsive Therapy Studies (3 papers). K. Hewett collaborates with scholars based in United Kingdom, United States and Poland. K. Hewett's co-authors include Anthony H. Dickenson, Henry J McQuay, Alok Krishen, Malini Iyengar, Jack G. Modell, Michelle Gee, Fabrizio Stocchi, Ulla Lepola, W. Chrzanowski and G. Evoniuk and has published in prestigious journals such as Brain Research, Pain and The Journal of Clinical Psychiatry.

In The Last Decade

K. Hewett

10 papers receiving 301 citations

Peers

K. Hewett

PHARM

ECP

PMH

PHYSI

Daniel L. Zimbroff United States

Michaela Strobelberger United States

G Beaumont United Kingdom

J. J. López-Ibor Spain

Maxime Barakat Canada

Tanya Ramey United States

H. Mikkelsen Switzerland

E. Martín-Sánchez Spain

Michael Serenko United States

Feighner Jp United States

Daniel L. Zimbroff United States

K. Hewett

103 ×0.7

PHARM

150 ×1.2

ECP

114 ×1.1

PMH

126 ×1.8

44 ×0.8

PHYSI

Citations per year, relative to K. Hewett K. Hewett (= 1×) peers Daniel L. Zimbroff

Countries citing papers authored by K. Hewett

Since Specialization

Citations

This map shows the geographic impact of K. Hewett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hewett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hewett more than expected).

Fields of papers citing papers by K. Hewett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Hewett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hewett. The network helps show where K. Hewett may publish in the future.

Co-authorship network of co-authors of K. Hewett

This figure shows the co-authorship network connecting the top 25 collaborators of K. Hewett. A scholar is included among the top collaborators of K. Hewett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Hewett. K. Hewett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hewett, K., et al.. (2019). Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events. Epilepsy & Behavior. 102. 106580–106580. 30 indexed citations

Hewett, K., et al.. (2009). Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder. Journal of Psychopharmacology. 24(4). 521–529. 40 indexed citations

Hewett, K., et al.. (2009). Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Journal of Psychopharmacology. 24(8). 1209–1216. 49 indexed citations

Hewett, K., W. Chrzanowski, Mark F. Schmitz, et al.. (2008). Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. Journal of Psychopharmacology. 23(5). 531–538. 47 indexed citations

Chrzanowski, W., Roxanne Rousseau, K. Hewett, et al.. (2006). P.2.c.006 Efficacy and safety of bupropion extended release in elderly patients with major depressive disorder. European Neuropsychopharmacology. 16. S315–S316. 4 indexed citations

Stocchi, Fabrizio, et al.. (2003). Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 64(3). 250–258. 91 indexed citations

Davidson, Jonathan, et al.. (2002). Post-traumatic stress disorder: Remission rates following paroxetine treatment. European Neuropsychopharmacology. 12. 347–347.

Baldwin, David S., et al.. (2001). Improving the impairment and disability associated with generalised anxiety disorder with paroxetine treatment. European Neuropsychopharmacology. 11. S309–S309. 2 indexed citations

McCafferty, James P., et al.. (2000). Paroxetine is effective in the treatment of generalized anxiety disorder: results from a randomized placebo-controlled flexible dose study. European Neuropsychopharmacology. 10. 347–348. 2 indexed citations

10.

Sullivan, Ann F., K. Hewett, & Anthony H. Dickenson. (1994). Differential modulation of α2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study. Brain Research. 662(1-2). 141–147. 8 indexed citations

11.

Hewett, K., Anthony H. Dickenson, & Henry J McQuay. (1993). Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study. Pain. 53(1). 59–63. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact